Translation of In-Clinic Gains to Gains in Daily Life
将诊所内的获益转化为日常生活中的获益
基本信息
- 批准号:10516654
- 负责人:
- 金额:$ 57.83万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2012
- 资助国家:美国
- 起止时间:2012-02-01 至 2027-07-31
- 项目状态:未结题
- 来源:
- 关键词:Activities of Daily LivingAddressAdhesive CapsulitisAdultAgeAlgorithmic SoftwareAwarenessBiologicalCaringCategoriesChildChildhoodClinicClinicalCluster AnalysisComplexComputer softwareConsumptionDataDevelopmentDiseaseEnvironmentFutureGoalsHumanImpairmentIndividualIndustryInfantIntervention StudiesLaboratoriesLifeLimb structureLongevityMapsMathematicsMeasurementMeasuresModelingMultiple SclerosisNeurologicOutcomeOutcome MeasureParticipantPatient Outcomes AssessmentsPatientsPediatric cohortPerformancePersonsPopulationReportingResearchResearch PersonnelSelf CareStrokeStructureTimeToddlerTranslationsUpper ExtremityUpper Extremity FractureValidationWorkWorld Health Organizationarmclinical careclinical decision-makingcohortdashboarddisabilityimpaired capacityimprovedmalignant breast neoplasmmotion sensorpatient populationpersonalized decisionpost strokerehabilitation researchrehabilitation servicerehabilitative careresearch studysensorwearable sensor technology
项目摘要
PROJECT SUMMARY/ABSTRACT
People seek out upper limb rehabilitation services to improve performance of activities in daily life, with
performance defined by the World Health Organization ICF model as what someone actually does in the
unstructured, free-living environment. Wearable, motion sensors now allow for direct measurement of upper
limb performance in daily life, but performance is rarely measured or considered in research and care. Data
from our 2nd cycle make it clear that improvements in impairments and/or functional capacity assessed in the
structured environment of the clinic or laboratory most often do not translate to improvements in performance
of activities in daily life. These data point to the clear need to move assessment of performance from the
specialized research realm into more universal use in upper limb research studies and clinical care. A major
barrier to more wide-spread use of sensors for routine upper limb performance assessment is lack of clinical
validation. An elegant solution to the many clinical validation challenges is to move from single variables in
individual populations to multivariate categories of upper limb performance in daily life that span patient
populations.
Our central hypothesis is that, despite the immense variability in biological conditions and their resulting upper
limb impairments and functional capacity profiles, upper limb performance in daily life can be organized into a
relatively small number of categories. Defined, validated categories could be used across populations to push
upper limb rehabilitation research forward and personalize clinical decision-making. We now propose to
expand and validate preliminary categories from stroke into a variety of conditions that send people to upper
limb rehabilitation services and result in upper limb disability. Wearable sensors will be used to assess upper
limb performance in a heterogeneous, longitudinal, observational cohort (N=340) of persons with (stroke,
multiple sclerosis, UL fracture, adhesive capsulitis, breast cancer) and without UL disability (controls), and a
retrospective, pediatric cohort (n ≥ 400) to address three aims. Aim 1 will identify and validate categories of
upper limb performance in daily life that can be applied across conditions that cause upper limb disability in
adults. Aim 2 will evaluate responsiveness to change across categories. And Aim 3 will explore how categories
identified in adults map to upper limb performance in childhood.
Expected outcomes at the end of the proposed cycle are validated categories of upper limb performance that
are responsive to change and span patient populations. These categories (and the software algorithms to
derive them) will immediately be available for intervention studies to measure outcomes that are most relevant
to patients. With anticipated advances in hardware and software over the next few years, future work will
implement validated categories readily into clinical rehabilitation care.
项目总结/文摘
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Catherine Lang其他文献
Catherine Lang的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Catherine Lang', 18)}}的其他基金
Variation in early motor function in autism, cerebellar injury and normal twins
自闭症、小脑损伤和正常双胞胎早期运动功能的变化
- 批准号:
10581581 - 财政年份:2021
- 资助金额:
$ 57.83万 - 项目类别:
Variation in early motor function in autism, cerebellar injury and normal twins
自闭症、小脑损伤和正常双胞胎早期运动功能的变化
- 批准号:
10391519 - 财政年份:2021
- 资助金额:
$ 57.83万 - 项目类别:
Variation in early motor function in autism, cerebellar injury and normal twins
自闭症、小脑损伤和正常双胞胎早期运动功能的变化
- 批准号:
10211899 - 财政年份:2021
- 资助金额:
$ 57.83万 - 项目类别:
ISCHEMIC CONDITIONING AS A NEURORECOVERY AGENT FOR STROKE
缺血调理作为中风的神经恢复剂
- 批准号:
9904733 - 财政年份:2016
- 资助金额:
$ 57.83万 - 项目类别:
ISCHEMIC CONDITIONING AS A NEURORECOVERY AGENT FOR STROKE
缺血调理作为中风的神经恢复剂
- 批准号:
9254586 - 财政年份:2016
- 资助金额:
$ 57.83万 - 项目类别:
Dose-Response of Movement Practice During Stroke Rehabilitation
中风康复期间运动练习的剂量反应
- 批准号:
8415529 - 财政年份:2012
- 资助金额:
$ 57.83万 - 项目类别:
Dose-Response of Movement Practice During Stroke Rehabilitation
中风康复期间运动练习的剂量反应
- 批准号:
8227456 - 财政年份:2012
- 资助金额:
$ 57.83万 - 项目类别:
Translation of in-clinic Gains to Gains in Daily Life After Stroke
将临床获益转化为中风后日常生活的获益
- 批准号:
9901564 - 财政年份:2012
- 资助金额:
$ 57.83万 - 项目类别:
Translation of in-clinic Gains to Gains in Daily Life After Stroke
将临床获益转化为中风后日常生活的获益
- 批准号:
9302890 - 财政年份:2012
- 资助金额:
$ 57.83万 - 项目类别:
Dose-Response of Movement Practice During Stroke Rehabilitation
中风康复期间运动练习的剂量反应
- 批准号:
8798674 - 财政年份:2012
- 资助金额:
$ 57.83万 - 项目类别:
相似海外基金
Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
- 批准号:
MR/S03398X/2 - 财政年份:2024
- 资助金额:
$ 57.83万 - 项目类别:
Fellowship
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
- 批准号:
EP/Y001486/1 - 财政年份:2024
- 资助金额:
$ 57.83万 - 项目类别:
Research Grant
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
- 批准号:
2338423 - 财政年份:2024
- 资助金额:
$ 57.83万 - 项目类别:
Continuing Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
- 批准号:
MR/X03657X/1 - 财政年份:2024
- 资助金额:
$ 57.83万 - 项目类别:
Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
- 批准号:
2348066 - 财政年份:2024
- 资助金额:
$ 57.83万 - 项目类别:
Standard Grant
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
- 批准号:
2341402 - 财政年份:2024
- 资助金额:
$ 57.83万 - 项目类别:
Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
- 批准号:
AH/Z505481/1 - 财政年份:2024
- 资助金额:
$ 57.83万 - 项目类别:
Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10107647 - 财政年份:2024
- 资助金额:
$ 57.83万 - 项目类别:
EU-Funded
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10106221 - 财政年份:2024
- 资助金额:
$ 57.83万 - 项目类别:
EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
- 批准号:
AH/Z505341/1 - 财政年份:2024
- 资助金额:
$ 57.83万 - 项目类别:
Research Grant